Brief: Sartorius Stedim Biotech Invests $3 Mln In Minority Share In Nanotein Technologies
Aug 11 (Reuters) - Sartorius Stedim Biotech SA STDM.PA: SARTORIUS STEDIM BIOTECH AND NANOTEIN TECHNOLOGIES PARTNER TO ADVANCE CELL THERAPY MANUFACTURING WILL INVEST UP TO 3 MILLION US DOLLARS IN A MINORITY SHAREHOLDING IN NANOTEIN TECHNOLOGIES Source text: https://tinyurl.com/33ryfssj Further company coverage: STDM.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))